We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

85 hedge funds and large institutions have $727M invested in Beam Therapeutics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 32 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

220% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 10

127% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 11

20% more funds holding

Funds holding: 71 → 85 (+14)

3.23% more ownership

Funds ownership: 53.81% → 57.04% (+3.2%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less capital invested

Capital invested by funds: $776M → $727M (-$48.6M)

Holders
85
Holders Change
+14
Holders Change %
+19.72%
% of All Funds
1.72%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
25
Increased
32
Reduced
10
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$26.9M
2
BlackRock
BlackRock
New York
+$22.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.85M
4
State Street
State Street
Massachusetts
+$7.65M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.81M

Top Sellers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
-$20.1M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.4M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$10M
4
Millennium Management
Millennium Management
New York
-$9.48M
5
OFM
Omega Fund Management
Massachusetts
-$8.48M
Name Holding Trade Value Shares
Change 		Change in
Stake
CS
51
Credit Suisse
Switzerland
$218K +$219K +8,821 New
PCM
52
Prelude Capital Management
New York
$138K – – –
Legal & General Group
53
Legal & General Group
United Kingdom
$123K +$56.1K +2,260 +83%
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
$123K +$124K +5,000 New
Bank of America
55
Bank of America
North Carolina
$111K -$103K -4,164 -48%
UBS Group
56
UBS Group
Switzerland
$110K -$68.8K -2,774 -38%
AIP
57
Ameritas Investment Partners
Nebraska
$74K +$48.6K +1,961 +187%
US Bancorp
58
US Bancorp
Minnesota
$74K +$74.4K +3,000 New
GT
59
Glenmede Trust
Pennsylvania
$73K +$74.4K +3,000 New
FHA
60
Flagship Harbor Advisors
Massachusetts
$70K – – –
Citigroup
61
Citigroup
New York
$52K -$45.9K -1,852 -47%
Bank of Montreal
62
Bank of Montreal
Ontario, Canada
$45K +$16.3K +659 +67%
Canada Life
63
Canada Life
Manitoba, Canada
$35K – – –
MAM
64
Meeder Asset Management
Ohio
$34K +$34.1K +1,375 New
BCV
65
Banque Cantonale Vaudoise
Switzerland
$25K +$24.8K +1,000 New
LWM
66
Liberty Wealth Management
California
$25K +$24.8K +1,000 New
EWM
67
Endurance Wealth Management
Rhode Island
$22K – – –
BG
68
Bollard Group
Massachusetts
$20K – – –
Rockefeller Capital Management
69
Rockefeller Capital Management
New York
$19K +$19.8K +800 New
CAPTRUST Financial Advisors
70
CAPTRUST Financial Advisors
North Carolina
$17K – – –
CSS
71
Cubist Systematic Strategies
Connecticut
$15K +$4.96K +200 +50%
HI
72
Hudock Inc
Pennsylvania
$12K – – –
BDWM
73
Brewin Dolphin Wealth Management
Ireland
$9.85K +$9.92K +400 New
Macquarie Group
74
Macquarie Group
Australia
$9K – – –
First Manhattan
75
First Manhattan
New York
$9K +$9.92K +400 New
1 2
3
4

BEAM Hedge Fund Activity: Q3 2020 in Review

85 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2020, worth a combined $727M — down 6.3% from $776M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BEAM positions and 11 closed out — a net gain of 14 holders — while 32 added to existing stakes and 10 trimmed.

The largest buyer was Vanguard Group, adding an estimated $26.9M. The largest seller was Fidelity International, cutting an estimated $20.1M.

  • 85 institutional investors held Beam Therapeutics (BEAM) as of Q3 2020, up from 71 in Q2 2020.
  • Funds reported $727M of Beam Therapeutics stock for Q3 2020, down 6.3% quarter-over-quarter.
  • 25 funds opened new Beam Therapeutics positions in Q3 2020 and 11 closed out, a net change of +14 holders.
  • The largest Beam Therapeutics buyer in Q3 2020 was Vanguard Group, an estimated $26.9M added.
  • The largest Beam Therapeutics seller in Q3 2020 was Fidelity International, an estimated $20.1M sold.

Based on aggregated 13F filings for Q3 2020.